Physician profile
Christopher H Bailey
NPI 1871989301
$13,439.89
in general payments reported to CMS, 2019-2025
29 companies · $2,148 in 2025
The $2,148 reported for 2025 was more than what 80% of Pain Medicine providers received nationally (typical 2025 total: $515).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,665 · 2020: $672 · 2021: $917 · 2022: $3,739 · 2023: $1,613 · 2024: $2,686 · 2025: $2,148.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,167 · Travel and Lodging: $1,154 · Consulting Fee: $125.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,167.49 |
| Travel and Lodging | $1,154.45 |
| Consulting Fee | $125.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $3,153.05 | 2021-2025 | Intracept, Bionic Navigator, Wavewriter Alpha Prime 16 |
| Abbott Laboratories | $2,312.90 | 2019-2025 | Eterna, Proclaim |
| Nevro Corp. | $2,101.49 | 2019-2024 | Senza |
| Nalu Medical, INC. | $1,909.98 | 2021-2025 | Nalu Neurostimulation System |
| Spinal Simplicity, LLC | $1,458.89 | 2022 | |
| Medtronic USA, INC. | $847.17 | 2019-2020 | |
| Vertos Medical, INC. | $778.93 | 2020-2024 | Mild Device Kit |
| Globus Medical, INC. | $112.77 | 2025 | Omnia |
| Relievant Medsystems, INC. | $107.95 | 2020 | |
| Pacira Therapeutics, INC. | $106.29 | 2021 | |
| Collegium Pharmaceutical, INC. | $67.85 | 2020-2022 | |
| Saluda Medical Americas, INC. | $55.53 | 2023 | Evoke Scs |
| Ferring Pharmaceuticals INC. | $52.29 | 2021-2023 | Euflexxa |
| Spr Therapeutics, INC | $52.10 | 2022 | |
| Averitas Pharma INC. | $42.48 | 2023 | Qutenza |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biodelivery Sciences International, INC. | $34.43 | 2021 | |
| Novartis Pharmaceuticals Corporation | $33.30 | 2020-2021 | |
| Stratus Medical, LLC | $25.15 | 2020 | |
| Abbvie INC. | $21.61 | 2025 | |
| Stimwave Technologies Incorporated | $21.25 | 2022 | |
| Curonix LLC | $20.54 | 2023 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Lilly USA, LLC | $18.66 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $17.78 | 2025 | Journavx |
| Scilex Pharmaceuticals INC. | $17.20 | 2021 | |
| Painteq LLC | $15.36 | 2022 | |
| Amgen INC. | $15.30 | 2021 | |
| Avanos Medical | $14.20 | 2025 | Trivisc Sodium Hyaluronate |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.87 | 2023 | Relistor |
| Arbor Pharmaceuticals, INC. | $11.57 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Bailey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.